Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net loss	$ (1,986,557)	$ (4,657,894)	$ (991,126)	$ (976,063)	$ (6,062,360)	$ (3,156,299)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of debt discount and deferred finance costs					1,591,261	88,479
Amortization of intangible assets	12,841		12,841		245,104	38,524
Stock-based compensation					2,147,591	340,674
Depreciation on development equipment					27,987
Issuance of common stock in lieu of cash for services						418,136
Change in fair value of derivative	(49,992)				(60,504)		$ (870,268)
Loss on debt conversion	88,817				254,884
Changes in operating assets and liabilities:
Prepaid expenses and other current assets					104,071	35,175
Accounts payable and accrued expenses					644,329	329,760
Accounts payable to related party					(216,680)	569,256
Net cash used in operating activities					(1,324,317)	(1,336,295)
Cash flows from investing activities:
Cash acquired in mergers						182,883
Net cash provided by investing activities						182,883
Cash flows from financing activities:
Proceeds from sales of common stock, net of costs						83,120
Proceeds from Payroll Protection Plan					250,000
Proceeds from short term loan, related party					70,000	148,000
Proceeds from private placement					2,304,541
Net cash provided by financing activities					2,624,541	1,167,120
Net increase in cash and restricted cash					1,300,224	13,708
Cash - beginning of period		$ 81,964		$ 2,498	81,964	2,498	2,498
Cash and restricted cash - end of period	$ 1,382,188		$ 16,206		1,382,188	16,206	$ 81,964
Non cash investing and financing activities:
Common shares issued upon partial conversion of debt					900,569
Recapitalization under reverse merger						3,727,752
Beneficial Conversion Feature on convertible debt and restricted common shares						684,140
Common stock issued for settlement of accounts payable						$ 238,090